Ceftibuten clinical trials
How each study uses Ceftibuten is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 20 Dec 1995 · CEDAX · NDA 050685 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 1
Basilea Pharmaceutica (3) · Pfizer (2) · Qpex Biopharma, Inc. (1) · Achaogen, Inc. (1) · IRCCS Burlo Garofolo (1)
Often tested with
Tested in the same studies.
Ledaborbactam etzadroxil (2) · QPX7831 (1) · PF-07612577 (1) · ACHN-789 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Cephalosporins source
Studies
Open first, then newest update. How each study uses Ceftibuten is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adults (18-55 Years)CompletedPhase 1Basilea PharmaceuticaNCT06665555Written as ceftibuten
- P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy ParticipantsCompletedPhase 1Qpex Biopharma, Inc.NCT06079775Written as Ceftibuten
- Food Effect on Ceftibuten/VNRX-7145 in Healthy ParticipantsCompletedPhase 1Basilea PharmaceuticaNCT05527834Written as Ceftibuten
- VNRX-7145 Drug-Drug Interaction in Healthy Adult VolunteersCompletedPhase 1Basilea PharmaceuticaNCT04877379Written as VNRX-5024 (ceftibuten)
- To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy AdultsCompletedPhase 1PfizerNCT06593054Written as Ceftibuten
- A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.CompletedPhase 1PfizerNCT05554237Written as PF-06264006
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789CompletedPhase 1Achaogen, Inc.NCT03163550Written as ACHN-383
- Short-term Antibiotic Therapy for Pyelonephritis in ChildhoodTerminatedPhase 3IRCCS Burlo GarofoloNCT00724256Written as ceftibuten
Given beside what is tested · 3 — Ceftibuten is usual care or a partner of the new treatment
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose CombinationRecruitingPhase 1Basilea PharmaceuticaNCT06733675Written as Ceftibuten
- Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal FunctionCompletedPhase 1Basilea PharmaceuticaNCT05488678Written as Ceftibuten
- PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal ImpairmentCompletedPhase 1Qpex Biopharma, Inc.NCT06157242Written as Ceftibuten
Codes
What other systems call Ceftibuten · ClinicalTrials.gg INT006790
- MeSH (NLM) D000077722CeftibutenConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) IW71N46B4YCEFTIBUTENConfirmed FDA, NLM, Wikidata
- RxNorm 20492Confirmed FDA, Wikidata
- Wikidata Q419521ceftibutenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61666CeftibutenOne source FDA
- DrugBank DB01415One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077722 | Ceftibuten | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | IW71N46B4Y | CEFTIBUTEN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 20492 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419521 | ceftibuten | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61666 | Ceftibuten | One source FDA |
| DrugBank | DB01415 | — | One source Wikidata |
Also registered as ceftibuten dihydrate (UNII 62F4443RWP · RxNorm 1297879).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.